With the recent buzz surrounding the dangers of obstructive sleep apnea (OSA) and the growing number of individuals who remain undiagnosed, treatment options for patients are becoming more prevalent than ever before. As millions of Americans continue to shy away from traditional CPAP therapy due to its overall lack of comfort and highly invasive nature, oral appliances provided by dentists are gaining extreme popularity.
Mandibular Advancement Devices (MADs) move the lower jaw forward further opening the upper airway to allow for easy breathing. Of the many MADs on the market today, the Oravan device, manufactured by OravanOSA, has captured the attention of many in the sleep industry. Last week, Sleep Review Magazine introduced the device to its readers as an FDA cleared and patented dorsal fin appliance for treating mild to moderate obstructive sleep apnea and snoring. It's the only device on the market with a true open anterior design featuring no anterior coverage, promoting extremely high patient compliance rates. The company also recently redesigned the fins of the device to make them less bulky, maximizing comfort levels for the patient...